STAT1 and atherosclerosis: Suppressor of cytokine signaling‐1‐derived peptides, which inhibit both STAT‐1 and ‐3 activation, improved inflammation and atherosclerosis in diabetic mice58 so this represents one possible therapeutic avenue.